Discharge During the Weekend After Cardiac Surgery Is Not Associated with Readmissions

According to this new work (soon to be published in Ann Thorac Surg), discharging a patient during the weekend or a holiday after cardiac surgery is not associated with higher rates of readmission compared with patients discharged during weekdays.

El alta en el mismo día luego de una angioplastia coronaria es cada vez más popular pero todavía no es reglaA total of 4877 patients were discharged after cardiac surgery in high-volume sites in the United States. Among them, about 1 every 5 patients was discharged on a Saturday, Sunday, or holiday, and 11.4% had to be readmitted within 30 days.

 

Conversely, 10.9% of the patients who went home on a weekday had to go back to the hospital within the same period of time. The difference between cohorts is not significant.


Read also: Next-Day Discharge after TAVR: Is It Viable?


Discharge is a task that begins immediately after surgery and that must include a patient’s family so that, once s/he gets home, s/he has the necessary resources to meet expectations.

 

Several studies in diverse clinical contexts have shown an increase in the number of events upon admission during the weekend; however, according to this work, going home on a weekend does not entail the same risks.

 

Some comorbidities (older age, chronic obstructive pulmonary disease, dialysis, pleural effusion after surgery, or neurological complications) had previously been associated with more readmissions but were not predictors in this cohort.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions.


Smoking and beta-blocker use were actually associated with more readmissions. However, in the case of beta-blockers, the problem may not lie in their use, but in the fact that they suggest a higher burden of ischemic disease.

 

Original title: Day of Discharge Does Not Impact Hospital Readmission After Major Cardiac Surgery.

Reference: Sanaiha Y et al. Ann Thorac Surg 2018; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...